Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetanus toxin, also known as tetanospasmin, is a highly potent neurotoxin produced by the vegetative cells of Clostridium tetani [4, 5]. It is the primary virulence factor responsible for tetanus, a life-threatening condition characterized by generalized muscle rigidity and violent spasms [18, 19]. The toxin is synthesized as a single 150 kDa polypeptide chain that is subsequently cleaved into a heavy chain (100 kDa) and a light chain (50 kDa) linked by a disulfide bond [5, 13]. The heavy chain mediates high-affinity binding to gangliosides on motor neurons and facilitates the toxin's retrograde transport to the central nervous system, while the light chain functions as a zinc-dependent metalloproteinase [13, 14]. Once inside inhibitory interneurons, the light chain cleaves vesicle-associated membrane protein 2 (VAMP-2/synaptobrevin), effectively blocking the release of inhibitory neurotransmitters such as GABA and glycine [4, 13]. This blockade results in the characteristic over-excitation of motor neurons and painful muscle contractions [5, 18]. Therapeutic strategies involve the use of tetanus immune globulin (TIG) or monoclonal antibodies like siltartoxatug to neutralize the toxin in the circulation before it can bind to neuronal receptors [1, 12, 16].
Neutralization of circulating tetanus toxin to prevent its binding to neuronal gangliosides and subsequent internalization; inhibition of the toxin's zinc-metalloproteinase activity which cleaves VAMP-2/synaptobrevin.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetanus toxin (Tetanospasmin) (TeNT).